Sage raises $175M days after shares pop

CNS company Sage Therapeutics Inc. (NASDAQ:SAGE) raised $175 million through the sale of 4.4 million shares at $39.75 in a follow-on underwritten by JPMorgan, Goldman Sachs, Cowen, Leerink, Canaccord Genuity and William Blair.

Sage shares rose 12% to $40.92 on Tuesday after FDA granted breakthrough therapy designation to postpartum depression candidate SAGE-547 (see BioCentury Extra, Sept. 6). ...